BIO-key Partners with Angola-based Pixel Infinito, Expanding the Reach of its Identity and Access Management Solutions in Africa

LUANDA, Angola and WALL, N.J. , May 01, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced a strategic partnership with Infinito to bring its innovative IAM solutions to customers across Angola who are looking to enhance their cybersecurity with first in class identity and access solutions.

With a highly qualified and experienced team, Pixel Infinito provides high quality services in software development, management systems, data analysis, information security, network infrastructure and technical support. Partnerships with renowned brands ensures that Pixel Infinito has access to the latest technologies and tools to meet the specific needs of each client. Pixel offers innovative and customized solutions to help its clients achieve their business objectives and enhance their competitive position.

Pixel joins BIO-key’s global (CAP) program which makes it easy for partners to develop new recurring revenue streams via BIO-key’s full line of solutions, including its award-winning platform. PortalGuard supports multi-factor authentication with unique IBB methods, single sign-on, and self-service password reset, along with hardware solutions, such as fingerprint scanners and security keys. BIO-key solutions provide customers unparalleled flexibility in securing all their access management needs and use cases.

Founder and General Manager of Pixel Infinito, Marcos Lisboa commented, “We are very excited to establish this strategic partnership with BIO-key to further expand our offerings of industry leading information security solutions. Together, we will be able to provide complete and highly secure solutions to meet our customers' security needs in Angola and beyond.”

“With this partnership we are further expanding our international channel program in Africa,” said José Francês, VP of Sales for Africa, Europe, and Brazil at BIO-key. “Pixel Infinito offers us access to Angola and adjacent markets, including non-English speaking areas, with our unique IAM and Identity-Bound Biometrics solutions, leveraging Pixel’s strong reputation and local relationships as a well-respected cybersecurity VAR.”

About BIO-key International, Inc. ()

BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software managing millions of users. Its cloud-based PortalGuard IAM solution provides cost-effective, easy to deploy, convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's patented software and hardware solutions, with industry-leading Identity-Bound Biometric (IBB) capabilities, enable large-scale Identity-as-a-Service (IDaaS) solutions, as well as customized on premises solutions.

About Pixel Infinito ()

Pixel Infinito is an Information Technology (IT) company based in Angola, which acts as a partner of several renowned brands in the market, including Microsoft, IBM, Honeywell, Lenovo and others. The company offers customized technology solutions to help customers achieve their business objectives, using advanced technologies to solve process problems and improve operational efficiency. Pixel aims to help transform companies, by providing and enabling the most modern technology in its markets.

BIO-key Safe Harbor Statement

All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors'' in our Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our Company, in particular, have been material, are changing rapidly, and cannot be predicted.

Engage with BIO-key

Facebook – Corporate:   

LinkedIn – Corporate:   

Twitter – Corporate:

Twitter – Investors:

StockTwits:

Investor Contacts

William Jones, David Collins

Catalyst IR

  

212-924-9800